Edition:
India

Huntsman Corp (HUN.N)

HUN.N on New York Stock Exchange

24.79USD
18 Apr 2019
Change (% chg)

$-0.02 (-0.08%)
Prev Close
$24.81
Open
$24.92
Day's High
$25.25
Day's Low
$24.74
Volume
538,517
Avg. Vol
725,983
52-wk High
$33.55
52-wk Low
$17.59

About

Huntsman Corporation is a manufacturer of differentiated organic chemical products and of inorganic chemical products. The Company operates all of its businesses through its subsidiary, Huntsman International LLC (Huntsman International). The Company operates through five segments: Polyurethanes, Performance Products, Advanced... (more)

Overall

Beta: 2.29
Market Cap(Mil.): $5,789.03
Shares Outstanding(Mil.): 233.52
Dividend: 0.16
Yield (%): 2.62

Financials

Akorn to Delaware justices: Chancery’s MAC opinion is ‘new blueprint for remorseful buyers’

The global pharmaceutical company Fresenius received a rude shock in the summer of 2017 when Akorn, the generic drugmaker Fresenius had agreed to acquire for $4.75 billion, reported its quarterly financial results. The results were terrible – far worse than Fresenius’ gloomiest projection. Fresenius CEO Stephan Sturm considered the Akorn results the biggest personal embarrassment of his career. Within weeks, the company hired Paul Weiss Rifkind Wharton & Garrison to advise it could w

01 Nov 2018

Earnings vs. Estimates